A Study of Diffusing Alpha Radiation Therapy for Patients With Breast Carcinoma in Frail or Elderly Patients.
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-120
SponsorAlpha Tau Medical LTD.
About this trial
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for the treatment of newly diagnosed or Recurrent Breast Carcinoma in frail or elderly patients.
Eligibility criteria
Qualifiers
Histologically confirmed invasive breast tumor with no involvement of skin within 12 months.
Tumor size ≤ 4 centimeters in the longest diameter.
Tumor is not deemed as resectable with radical surgery or the patient does not wish to go through surgery
De-novo or recurrent lesions.
Disqualifiers
T4 category with skin involvement.
Ductal carcinoma in situ.
Inflammatory breast carcinoma.
Longest tumor diameter >4 cm.
Trial design
Treatments tested in this trial
- Diffusing Alpha Radiation Emitters Therapy (DaRT)
Treatment groups
10 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov